Related Experiment Video
Updated: Aug 3, 2026

Intrastriatal Injection of Autologous Blood or Clostridial Collagenase as Murine Models of Intracerebral Hemorrhage
Published on: July 3, 2014
Massive intravascular hemolysis is an important factor in Clostridium perfringens-induced bacteremia
Ai Suzaki1,2, Shihoko Komine-Aizawa3, Hiroyuki Nishiyama4
1Division of Microbiology, Department of Pathology and Microbiology, Nihon University School of Medicine, 30-1 Oyaguchi-Kamicho, Itabashi, Tokyo, 173-8610, Japan. suzaki.ai@nihon-u.ac.jp.
Abstract:
Clostridium perfringens bacteremia is rare but often fatal. In particular, once bacteremia with massive intravascular hemolysis (MIH) occurs, the mortality rate is extremely high. However, because of its rarity, the detailed pathophysiology of this fulminant form of bacteremia is unclear. To elucidate the detailed pathogenesis of MIH, we retrospectively reviewed the data of all patients with C. perfringens bacteremia from two university hospitals from 2000 to 2014. The medical records and laboratory data of 60 patients with bacteremia, including 6 patients with MIH and 54 patients without MIH, were analyzed. Patients with MIH had higher rates of intense pain at onset, impaired consciousness, shock at presentation, hematuria, metabolic acidosis, and gas formation than patients without MIH. The antibiotic susceptibility of the clinical isolates was not significantly different between the two groups. All patients with MIH, although treated with appropriate antimicrobial agents, died within 26 h of admission due to rapidly progressive acute lung injury or acute respiratory distress syndrome, and the median time from arrival at the hospital to death was only 4 h and 20 min. When clinicians observe intravascular hemolysis in blood samples from patients with characteristic symptoms of MIH, they should prepare for a severe disease outcome. The underlying pathophysiology of fulminant cases must be investigated.
Insights
Clostridium perfringens bacteremia with massive intravascular hemolysis (MIH) is rare and highly fatal. Early recognition of MIH symptoms is crucial for anticipating severe outcomes in patients with this infection.
Area of Science:
- Infectious Diseases
- Hematology
- Critical Care Medicine
Background:
- Clostridium perfringens bacteremia is a rare but severe infection.
- Massive intravascular hemolysis (MIH) associated with C. perfringens bacteremia carries an extremely high mortality rate.
- The pathophysiology of fulminant C. perfringens bacteremia with MIH remains poorly understood due to its rarity.
Purpose of the Study:
- To elucidate the detailed pathogenesis of massive intravascular hemolysis (MIH) in Clostridium perfringens bacteremia.
- To identify clinical and laboratory differences between patients with and without MIH.
- To understand the outcomes and time course of fulminant C. perfringens bacteremia with MIH.
Main Methods:
- Retrospective analysis of medical records and laboratory data from patients with C. perfringens bacteremia.
- Comparison of clinical characteristics and outcomes between patients with MIH and those without MIH.
- Review of data from two university hospitals spanning from 2000 to 2014.
Main Results:
- Patients with MIH presented with more intense pain, impaired consciousness, shock, hematuria, metabolic acidosis, and gas formation.
- Antibiotic susceptibility patterns did not significantly differ between MIH and non-MIH groups.
- All patients with MIH died within 26 hours of admission, primarily from acute lung injury or ARDS, with a median survival of 4 hours 20 minutes.
Conclusions:
- Massive intravascular hemolysis in C. perfringens bacteremia indicates a severe, rapidly fatal outcome.
- Clinicians should be vigilant for MIH symptoms and prepare for critical illness.
- Further investigation into the pathophysiology of fulminant C. perfringens bacteremia with MIH is warranted.
More Related Videos
Related Concept Videos
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Determinants of Bacterial Pathogenicity and Virulence
Amebiasis
Hemorrhagic Stroke l: Introduction
Hemorrhagic Stroke ll: Pathophysiology
Bacterial Meningitis II: Pathophysiology

